Supplemental material for The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysis

Supplemental Material for The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysis by Melanie P Jensen, Oliver J Ziff, Gargi Banerjee, Gareth Ambler and David J Werring in European Stroke Journal</p

Supplementary Data and Tables -Supplemental material for A survey of opinion: When to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation?

<p>Supplemental material, Supplementary Data and Tables for A survey of opinion: When to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation? by David Munn, Azmil H Abdul-Rahim, Urs Fischer, David J Werring, Thompson G Robinson and Jesse Dawson in European Stroke Journal</p

Supplemental material for Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline

Supplemental Material for Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline by Catharina JM Klijn, Maurizio Paciaroni, Eivind Berge, Eleni Korompoki, Janika Kõrv, Avtar Lal, Jukka Putaala and David J Werring in European Stroke Journal</p

sj-docx-1-wso-10.1177_17474930231215660 – Supplemental material for Prevalence, patterns, and predictors of patient-reported non-motor outcomes at 30 days after acute stroke: Prospective observational hospital cohort study

Supplemental material, sj-docx-1-wso-10.1177_17474930231215660 for Prevalence, patterns, and predictors of patient-reported non-motor outcomes at 30 days after acute stroke: Prospective observational hospital cohort study by Hatice Ozkan, Gareth Ambler, Gargi Banerjee, Simone Browning, Alex P Leff, Nick S Ward, Robert J Simister and David J Werring in International Journal of Stroke</p

sj-docx-1-eso-10.1177_23969873221099478 – Supplemental material for European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin

Supplemental material, sj-docx-1-eso-10.1177_23969873221099478 for European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin by Marta Rubiera, Ana Aires, Kateryna Antonenko, Sabrina Lémeret, Christian H Nolte, Jukka Putaala, Renate B Schnabel, Anil M Tuladhar, David J Werring, Dena Zeraatkar and Maurizio Paciaroni in European Stroke Journal</p

sj-docx-1-eso-10.1177_23969873231223814 – Supplemental material for Peri-hematomal edema shape features related to 3-month outcome in acute supratentorial intracerebral hemorrhage

Supplemental material, sj-docx-1-eso-10.1177_23969873231223814 for Peri-hematomal edema shape features related to 3-month outcome in acute supratentorial intracerebral hemorrhage by Fiona Dierksen, Anh T Tran, Tal Zeevi, Ilko L Maier, Adnan I Qureshi, Pina C Sanelli, David J Werring, Ajay Malhotra, Guido J Falcone, Kevin N Sheth and Seyedmehdi Payabvash in European Stroke Journal</p

sj-pdf-2-eso-10.1177_23969873221099478 – Supplemental material for European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin

Supplemental material, sj-pdf-2-eso-10.1177_23969873221099478 for European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin by Marta Rubiera, Ana Aires, Kateryna Antonenko, Sabrina Lémeret, Christian H Nolte, Jukka Putaala, Renate B Schnabel, Anil M Tuladhar, David J Werring, Dena Zeraatkar and Maurizio Paciaroni in European Stroke Journal</p

sj-docx-1-wso-10.1177_17474930211062478 – Supplemental material for MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage

Supplemental material, sj-docx-1-wso-10.1177_17474930211062478 for MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage by Ghil Schwarz, Gargi Banerjee, Isabel C Hostettler, Gareth Ambler, David J Seiffge, Hatice Ozkan, Simone Browning, Robert Simister, Duncan Wilson, Hannah Cohen, Tarek Yousry, Rustam Al-Shahi Salman, Gregory Y H Lip, Martin M Brown, Keith W Muir, Henry Houlden, Rolf Jäger and David J Werring in International Journal of Stroke</p

sj-pdf-1-wso-10.1177_17474930211050749 - Supplemental material for The coronal plane maximum diameter of deep intracerebral hemorrhage predicts functional outcome more accurately than hematoma volume

Supplemental material, sj-pdf-1-wso-10.1177_17474930211050749 for The coronal plane maximum diameter of deep intracerebral hemorrhage predicts functional outcome more accurately than hematoma volume by Stefan P Haider, Adnan I Qureshi, Abhi Jain, Hishan Tharmaseelan, Elisa R Berson, Shahram Majidi, Christopher G Filippi, Adrian Mak, David J Werring, Julian N Acosta, Ajay Malhotra, Jennifer A Kim, Lauren H Sansing, Guido J Falcone, Kevin N Sheth and Seyedmehdi Payabvash in International Journal of Stroke</p

Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)

Background: Patients with wake-up ischemic stroke are frequently excluded from thrombolytic treatment due to unknown symptom onset time and limited availability of advanced imaging modalities. The Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST) is a randomized controlled trial of intravenous tenecteplase 0.25 mg/kg and standard care versus standard care alone (no thrombolysis) in patients who wake up with acute ischemic stroke and can be treated within 4.5 h of wakening based on non-contrast CT findings. Objective: To publish the detailed statistical analysis plan for TWIST prior to unblinding. Methods: The TWIST statistical analysis plan is consistent with the Consolidating Standard of Reporting Trials (CONSORT) statement and provides clear and open reporting. Discussion: Publication of the statistical analysis plan serves to reduce potential trial reporting bias and clearly outlines the pre-specified analyses. Trial registration: ClinicalTrials.govNCT03181360. EudraCT Number 2014-000096-80. WHO ICRTP registry number ISRCTN10601890